Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.

Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Am Heart J. 2016 Jul; 177:1-8.

View in: PubMed

subject areas

Acute Coronary Syndrome
Adenosine
Aged
Antibodies, Monoclonal
Aspirin
Cardiovascular Diseases
Drug Therapy, Combination
Drug-Eluting Stents
Female
Graft Occlusion, Vascular
Hemorrhage
Humans
Immunoglobulin Fab Fragments
Male
Middle Aged
Myocardial Infarction
Peptides
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Purinergic P2Y Receptor Antagonists
Stroke
Thrombosis
Ticlopidine
Tyrosine

authors with profiles

Robert Harrington